Sleep Aids in the US

September 2023 | 28 pages | ID: SEA89A0029BEN
Euromonitor International Ltd

Abstracts

Maintaining the trend from 2022, sleep aids is expected to continue to face decline in retail current value and volume terms in 2023, further offsetting the strong growth surge seen in the category during the peak pandemic years of 2020 and 2021, when consumers dealt with intense stress-related insomnia. While the soft performance for sleep aids in the past two years can be interpreted as a slow return to its pre-pandemic equilibrium, consumers are still experiencing sleep anxieties due to worri...

Euromonitor International's Sleep Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Sleep Aids market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

SLEEP AIDS IN THE US
KEY DATA FINDINGS
2023 DEVELOPMENTS
Sleep aids continues to witness value and volume declines amidst softening consumer demand
Rise of “super supplements” with ingredient-driven sleep+ combination benefits hinders growth of sleep aids
Labelling controversies and paediatric melatonin incidents halt growth of “natural” sleep aids and gummy products
PROSPECTS AND OPPORTUNITIES
What will be the next spotlight ingredient after melatonin?
Sleep tech and alternative delivery formats
Utilising e-commerce and digitalisation to navigate an uncertain and diverging category
CATEGORY DATA
Table 1 Sales of Sleep Aids: Value 2018-2023
Table 2 Sales of Sleep Aids: % Value Growth 2018-2023
Table 3 NBO Company Shares of Sleep Aids: % Value 2019-2023
Table 4 LBN Brand Shares of Sleep Aids: % Value 2020-2023
Table 5 Forecast Sales of Sleep Aids: Value 2023-2028
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2023-2028
CONSUMER HEALTH IN THE US
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2022-2023
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources